Wuhan Thalys Med Tech Co Ltd (603716) — Cash Flow Reinvestment Rate
Wuhan Thalys Med Tech Co Ltd (603716) has a Cash Flow Reinvestment Rate of 0.03x as of September 2025, reinvesting CN¥1.57 Million (capex CN¥1.57 Million ) from operating cash flow of CN¥54.57 Million. Check Wuhan Thalys Med Tech Co Ltd (603716) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Wuhan Thalys Med Tech Co Ltd Cash Flow Reinvestment Rate (2012–2024)
Historical reinvestment intensity for Wuhan Thalys Med Tech Co Ltd across 9 annual periods. Explore 603716 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Wuhan Thalys Med Tech Co Ltd (2012–2024)
Year-by-year capital reinvestment analysis for Wuhan Thalys Med Tech Co Ltd. For live market cap and broader valuation context, see market cap of Wuhan Thalys Med Tech Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.51x | CN¥50.33 Million | CN¥99.60 Million | CN¥23.21 Million | ▲ +41.5% |
| 2023 | 0.36x | CN¥44.94 Million | CN¥125.89 Million | CN¥40.83 Million | ▼ -87.5% |
| 2022 | 2.85x | CN¥80.02 Million | CN¥28.12 Million | CN¥54.64 Million | ▼ -90.3% |
| 2020 | 29.43x | CN¥292.68 Million | CN¥9.94 Million | CN¥127.70 Million | ▲ +1449.0% |
| 2019 | 1.90x | CN¥178.47 Million | CN¥93.92 Million | CN¥96.49 Million | ▲ +116.5% |
| 2015 | 0.88x | CN¥40.47 Million | CN¥46.11 Million | CN¥40.47 Million | ▼ -16.8% |
| 2014 | 1.06x | CN¥31.73 Million | CN¥30.07 Million | CN¥31.73 Million | ▼ 0.0% |
| 2013 | 1.06x | CN¥34.35 Million | CN¥32.54 Million | CN¥34.35 Million | ▼ -93.1% |
| 2012 | 15.20x | CN¥41.04 Million | CN¥2.70 Million | CN¥41.04 Million | — |